Oxeia to Enroll Patients in Concussion Symptom Therapy Clinical Trial
Oxeia Biopharmaceuticals plans to enroll 160 patients in a Phase 2b clinical trial of OXE103, therapy for persistent concussion symptoms.
Oxeia Biopharmaceuticals plans to enroll 160 patients in a Phase 2b clinical trial of OXE103, therapy for persistent concussion symptoms.
This research aims to monitor cognitive workload using a wearable cyber-physical system with a novel magnetocardiography sensor.
HitCheck announces it is the preferred cognitive assessment tool for Premiere Physical Therapy & Sports Performance and its clients.
Measuring brain wave levels could lead to more definitive methods of diagnosing concussions and determining return to play.
Read MoreAural Analytics, a provider of clinical-grade speech analytics, partners with HitCheck to solve in-game concussion protocol decision-making.
Read MoreThe initial severity of sport-related concussion, family history of a psychiatric disorder, and other factors predict further medical visits.
Read MoreBRAINBox Solutions receives a notice of allowance for a patent covering methods for detection of mTBI using Brain Derived Neurotrophic Factor.
Read MoreHyperbaric oxygen therapy significantly improves symptoms of post-concussion syndrome in children, a new study suggests.
Read MoreA clinical trial investigating the effects of treatments on recovery from a sport-related concussion is recruiting adolescent patients.
Read MoreNearly 1 in 3 adolescents reported elevated symptoms of depression in the first four weeks after concussion, according to a CHOP study.
Read MoreConcussion in grassroots rugby will be investigated in a new technology trial that could transform player safety around the globe.
Read MoreBlood test study suggests that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury.
Read MoreBritish Taekwondo, the National Governing Body for Taekwondo in Great Britain, announces a new partnership with TeachAids.
Read MoreUSA Karate officially announces a partnership with TeachAids to further understanding of the invisible injury of concussions.
Read MoreDifferent types of brain damage caused by a concussion may lead to similar symptoms in children, suggests a study published in eLife.
Read MoreWithin the first 60 days, HitCheck has raised over $70,000 in public funding through the StartEngine platform.
Read MoreBurke Rehabilitation Hospital launches a new Concussion Management Practice complementary to its existing concussion therapy program.
Read MoreTecTraum Inc announces complete enrollment status for a clinical trial that began in fall of 2019 using its flagship technology, pro2cool.
Read More